Bafa Bafa PT in Danaher Corporation (DHR) at $ 220 of $ 230
Danaher Corporation (NYSE: DHR) is one of the The best medical actions to buy now. On September 22, Bofa dropped the company’s target price at Danaher Corporation (NYSE: DHR) to $ 220 from $ 230 while maintaining a purchase rating in the shares. Danaher Corporation (DHR) is “Fool’s Gold”, laments Jim Cramer The firm told…